Abstract
To assess the ability of non-invasive cardiac output monitoring (NICOM), a novel method of non-invasive maternal hemodynamic assessment using bioreactance, in combination with first trimester biomarkers to predict the evolution of gestational hypertension (GH), pre-eclampsia (PE) and normotensive fetal growth restriction (FGR).
| Original language | English |
|---|---|
| Pages | S207-S207 |
| DOIs | |
| Publication status | Published - 1 Jan 2018 |
Keywords
- non-invasive cardiac output monitoring
- NICOM
- non-invasive maternal hemodynamic assessment
- bioreactance
- first trimester biomarkers
- gestational hypertension
- GH
- pre-eclampsia
- PE
- normotensive fetal growth restriction
- FGR